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Background: The application of nanotechnology in biology and medicine represents a significant paradigm shift in
the approach to the treatment of cancer. Evidence suggests that when exposed to near-infrared radiation (NIR),
carbon nanotubes (CNTs) dissipate a substantial amount of heat energy. We have developed a novel
nanocomposite polymer, polyhedral oligomeric silsesquioxane poly (carbonate-urea) urethane (POSS-PCU).
POSS-PCU displays excellent biocompatibility and has been used in making artificial organs as well as protective
coatings for medical devices.
Results: Functionalizing (or “coating”) CNTs with POSS-PCU confers biocompatibility and increase the amount of
heat energy generated, by enhancing dispersion. Here we demonstrate that POSS-PCU-functionalized multi-walled
CNTs (MWNTs) act synergistically together when exposed to NIR to thermally ablate cancer cells.
Conclusion: Given that POSS-PCU has already been used in human in first-in-man studies as trachea, lacrimal duct,
bypass graft and other organs, our long-term goal is to take POSS-PCU coated CNTs to clinical studies to address
the treatment of cancer by optimizing its therapeutic index and increasing its specificity via antibody conjugation.
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Carbon nanotubes (CNTs) were initially described as
“helical microtubules of graphitic carbon” by Sumio
Ijima (of NEC Corporation), in a letter to Nature in
1991 [1]. An unprecedented interest in its application
has arisen since then, with wide-ranging potentials from
being high-power energy storage devices [2], to thera-
peutic and diagnostic agents in cancer biology [3,4].
CNTs have a high optical absorbance in the near infra-
red (NIR) region [5] (700 nm to 1100 nm) and subse-
quently dissipate a high amount of heat energy. This
phenomenon can thus be exploited in a biomedical set-
ting to destroy cancer cells via photothermal ablation
[6,7] (Figure 1).* Correspondence: a.seifalian@ucl.ac.uk
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reproduction in any medium, provided the orGenerally, CNTs can be classified into two broad cat-
egories: multi-walled carbon nanotubes (MWNTs) and
single-walled carbon nanotubes (SWNTs). SWNTs can
be conceptualized as a rolled-up sheet of planar sp2
hybridized carbon atoms, while MWNTs are concentric
layers of SWNTs [8]. CNTs have exceptional tensile
strength [9] (in the gigapascal (GPa) region), and a very
high Young’s modulus [10] (in the tetrapascal (TPa) re-
gion), making them one of the strongest materials
known. It has been previously reported that MWNTs
display a higher thermal conductivity, compared to
SWNTs, as their larger diameters allow a greater num-
ber of phonon modes, resulting in longer phonon mean
free paths [11]. Due to the lack of endogenous chromo-
phores that absorb within the NIR spectrum, biological
membranes are highly transparent to NIR within wave-
lengths of 700 nm to 1100 nm [12]. Alluding to their
electronic band structures, CNTs can attain a very high
temperature (of up to 70°C) within minutes of exposure
to NIR lasers [13]. Exposure of CNTs to NIR laser would. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 A computer graphics rendering of photothermal ablation when POSS-PCU-functionalized CNTs are exposed to near infrared
(NIR) laser. CNTs are functionalized with a novel nanocomposite polymer, POSS-PCU, depicted as a translucent “coating” on the CNT wall.
Intense heat energy is dissipated, depicted by blue emission, which can be exploited to thermally ablate cancer cells.
Figure 2 Visual appearance of CNTs after functionalization with
POSS-PCU. A contains CNTs functionalized with 50% POSS-PCU,
while B contains 100% POSS-PCU. Non-covalent functionalization
with POSS-PCU via bath sonication confers solubility to CNTs.
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consequently causes cell death via coagulative necrosis.
This event is known as photothermal cancer ablation,
with rupturing cell membranes and denaturation of cel-
lular proteins.
We have previously developed a novel nanocomposite
polymer called polyhedral oligomeric silsesquioxane poly
(carbonate-urea) urethane (POSS-PCU, trade name UCL
Nano™). POSS-PCU is biocompatible [14], resistant to
degradation [15], and has potential applications for being
scaffolds for artificial organs [16], and coatings for
medical devices [17]. Indeed, first-in-man clinical studies
have already been conducted using POSS-PCU con-
structed three-dimensional (3D) biomimetic scaffolds
of trachea [18], lacrimal duct and bypass graft, with fa-
vorable results.
A major concern for the use of CNTs in biological sys-
tems is its insolubility and inherent toxicity. With proper
functionalization, for example with polyethylene glycol
(PEG), CNTs appear to be well-tolerated in animal stud-
ies [19]. Hence, we postulate the amphiphilic nature of
POSS-PCU would increase dispersion of CNTs in bio-
logical systems [20], as well as conferring biocompatibil-
ity. Furthermore, we also set out to investigate if the
increased dispersion of CNTs would affect temperature
changes during NIR laser exposure, as well as the effects
of photothermal ablation on a colorectal cancer cell line.
Results & discussion
Conferring solubility and biocompatibility via POSS-PCU
functionalization
Raw CNTs appear as a black powder-like substance, which
is insoluble in water. Upon functionalization with POSS-
PCU via bath sonication, the final product appears as a
homogenous mixture (Figure 2) suitable for biological
applications. The 2 main functionalization schemes are
covalent and non-covalent. Covalent functionalizationinvolves oxidation or cycloaddition reactions, which intro-
duces functional groups onto the side-walls of CNTs [13].
However, the intrinsic chemical harshness of covalent
functionalization disrupts the structure of CNTs, inter-
rupting its inherent attributes like Raman scattering and
photoluminescence [21]. In contrast, non-covalent func-
tionalization preserves the structural integrity of CNTs, as
it simply provides an external “coating”. Non-covalent
functionalization occurs via hydrophobic interactions or
π-π stacking of the aromatic rings [22]. Functionalization
via PEG phospholipids (PL-PEG) can render CNTs bio-
compatible while simultaneously increasing its circulation
time in biological systems [23]. Arising from this, we pos-
tulate that POSS-PCU would similarly interface with
CNTs via π-π stacking of its aromatic rings of the urea
hard segment (Figure 3) onto the wall of CNTs. TEM
images and UV/Vis/NIR analysis (Figures 4 and 5)
Figure 3 Skeletal formula of POSS-PCU. This novel nanocomposite polymer displays superior biocompatibility and has been used in
constructing scaffolds for artificial organs as well as protective coating for medical devices.
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PCU onto the surface of CNTs.
Raw CNTs are insoluble in water and biological sys-
tems. Upon non-covalent functionalization with POSS-
PCU, solubility was conferred, rendering it ready for use
in biological systems. POSS-PCU is highly compatible,
and its use in humans as a bioartificial trachea, bypass
graft and lacrimal duct underscores its potential usability
as a coating agent for nanoparticles as well. Unfunctio-
nalized CNTs are not appropriate for use in biological
systems, and we postulate that biocompatibility can be
conferred via functionalization with POSS-PCU.
Synergistic thermal effects of POSS-PCU and CNTs
As POSS-PCU has thermoplastic behavior, does not absorb
in the near infrared spectrum. Thus, when exposed to NIR
laser, the temperature of POSS-PCU remains constant at
room temperature. Our results reveal that the presence ofFigure 4 Transmission electron microscopy of CNTs. A shows
pristine CNTs (before functionalization), B shows POSS-PCU coated
CNTs (after functionalization).POSS-PCU does not simply maintain the temperature pro-
file curve (as one might expect due to its absence of heating
effect), but instead increases the temperature profile curve
when functionalized with CNTs.
Upon functionalization with POSS-PCU, CNTs were able
to attain a greater rate of temperature increase as well as a
higher final temperature of 88°C within ten minutes of NIR
laser exposure compared to non-functionalized CNTs
(p=0.0006). At both wattages, synergistic thermal effects
were observed, as POSS-PCU-CNT was able to attain a
higher temperature than POSS-PCU and CNTs alone
(Figure 6). At higher wattage, functionalization with 100%
POSS-PCU shows a greater increase in temperature com-
pared to 50% POSS-PCU. This is possibly due to the sig-
nificant greater magnitude of vibrational energy, which
manifests itself more synergistically at 100% POSS-PCU
functionalization due to its dispersion effects. 100% POSS-
PCU functionalization ensures that a greater surface area of
CNTs are exposed to NIR, hence increasing its heating
effects.
We have therefore successfully demonstrated that POSS-
PCU can not only confer solubility to CNTs, but also en-
hance its heating effects (Figure 7). This is attributed to
POSS-PCU acting like a surfactant when functionalized to
CNTs, increasing its dispersion in biological systems [20].
Consequently, the surface area to volume ratio of functio-
nalized CNTs would be increased, allowing more particles
per unit area to absorb the NIR laser, thereby producing a
higher rate of temperature increase as well as a higher final
temperature.
Enhanced cell kill using POSS-PCU-CNT complex
With the observation of increased thermal response to NIR
exposure, we proceeded to investigate if POSS-PCU-CNT
was able to thermally ablate cancer cells. A HT-29 human
colorectal cancer cell line was used as a model for photo-
thermal ablation. There was a slight decrease in cell num-
ber after incubation with CNTs (without laser), possibly
due to the inherent toxicity of CNTs. In contrast, treatment
with POSS-PCU-CNT (without laser) did not result in any
significant change in cell number, indicating that functiona-
lization with POSS-PCU had conferred a high degree of
Figure 5 Absorption spectra of POSS-PCU-CNT. At a wavelength of 700 nm, POSS-PCU shows greatest absorbance (red). Non-covalent
functionalization of POSS-PCU onto CNTs results in a higher absorbance at 700 nm (green), compared to unfunctionalized CNTs (blue).
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erature, a decrease in cell number (of around 50%) was
observed when (unfunctionalized) CNTs were irradiated
with NIR laser. More importantly, when POSS-PCU-CNT
was irradiated with NIR laser, there was a dramatic de-
crease in cell numbers, thermally ablating 95% of cancer
cells (p= 0.0000842) (Figures 8 and 9). Hence, we haveFigure 6 Synergistic thermal effects of POSS-PCU and CNTs. At both w
temperature increase and final temperature. POSS-PCU does not absorb in
of CNTs upon functionalization. At higher wattage, functionalization with 1
50% POSS-PCU.shown that POSS-PCU exerts a dual function: firstly by
providing biocompatibility to CNTs, and secondly by acting
synergistically with CNTs during exposure to NIR laser,
resulting in a greater temperature increase and enhanced
cell death.
We have successfully demonstrated that POSS-PCU-
functionalized CNTs have the ability to thermally ablateattages (0.1 W and 1 W), POSS-PCU-CNT displays a higher rate of
the NIR spectrum, but synergistically elevates the temperature profile
00% POSS-PCU shows a greater increase in temperature compared to
Figure 7 Thermograph of NIR irradiated POSS-PCU-CNT. POSS-PCU-CNT have a higher heating profile at 2.5 min (A), 5 min (B), 7.5 min (C),
and 10 min (D), compared to unfunctionalized CNTs.
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POSS-PCU-functionalized CNTs attain a higher max-
imum temperature as well as a higher cell death rate
compared to unfunctionalized CNTs. This has signifi-
cant implications in photothermal ablative techniques,
as it shows that cell death would only occur when func-
tionalized CNTs are exposed to NIR. It has to be noted
that the depth of penetration of NIR is only effect up to
a few centimeters; hence for non-superficial cancers,
delivery of NIR can be achieved using optical fibers.
Although the toxicology of CNTs due to its size is also a
current point of contention, current scientific consensus
dictates that functionalizing CNTs with biocompatible
molecules can confer biocompatibility to CNTS. We
have demonstrated a proof-of-concept that POSS-PCU
nanocomposite polymers can render CNTs biocompat-
ible as well as augmenting its intended clinical function
of photothermal cancer ablation.
Conclusions
In this study, we present a model of synergism between
CNTs and a novel nanocomposite polymer, POSS-PCU.
This manifests itself in terms of temperature increase
and the ability to thermally ablate cancer cells whenexposed to NIR laser. Furthermore, POSS-PCU confers
solubility and biocompatibility to CNTs, making it an
ideal functionalizing agent to address cancer. Future
work regarding cancer-specific antibody conjugation for
targeted therapy and in vivo studies would not only be
imperative, but integral for elucidating the biological
applications for CNTs and nanocomposite polymers.
Taken together, this work underscores the dual function-
ality and synergistic effects of POSS-PCU functionaliza-
tion, which could have implications and ramifications in
a wide-ranging area of nanomedicine.
Materials & methods
Carbon nanotubes (CNTs) and dunctionalization with
POSS-PCU
Pristine multi-walled carbon nanotubes (MWNTs) were
obtained from Nanothinx S.A. (Rio-Patras, Greece). They
had a mean diameter of 15 nm, and a mean length of
100 nm. The preparation of POSS-PCU has been described
elsewhere[24]. Briefly, 1 mg of MWNT was mixed with
1 mg of POSS-PCU (50% and 100%) in a glass scintillation
vial and 5 ml of water was added. The resultant mixture
was sonicated in a sonicator bath (Grant Instruments,
Cambridge, UK) for 60 minutes at room temperature.
Figure 8 Increased cell kill after functionalization with POSS-PCU. Flow cytometry results reveal that 47.3% (A) of cells were destroyed when
NIR is applied to pristine CNTs. Upon functionalization with POSS-PCU, a synergistic effect is observed, increasing cell kill to 95.12% (B).
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Visual characterization was conducted using a JEM-
2100 F transmission electron microscope (JEOL Ltd.
UK). Optical absorbance of CNT, POSS-PCU, andFigure 9 Effects of various treatment reagents on cancer cells. Pristine
functionalization with POSS-PCU, CNTs do not appear to be toxic to cance
cell kill compared to non-functionalized CNTs (p = 0.0006).POSS-PCU-CNT was obtained using a LAMBDA 1050
UV/Vis/NIR (PerkinElmer, UK). Scan parameters were as
follows: start (4000), number of scans (100), resolution
(4), units (%T), end (400), interval (4), shuttle (interleaved).CNTs display a certain degree of toxicity to cells. Upon
r cells. POSS-PCU-CNTs are able to elicit a highly significant degree of
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derivative and a 16-point reading.
Near infrared radiation (NIR) laser system and
temperature tracking
A NIR laser system (Thorlabs Ltd, UK) with a 808 nm laser
diode was used to irradiate CNTs. The laser diode control-
ler was set to either 2300 mA (1 W) or 1250 mA (0.5 W).
To prevent over-heating, the temperature controller was
set to 10 kΩ. Temperature tracking and thermal images
were obtained using a Thermacam™ SC500 thermal camera
(FLIR Systems, UK). CNTs were exposed to NIR irradiation
for 10 minutes, and temperature changes were recorded
every minute.
Thermal ablation of cancer cells
A HT-29 human colorectal cancer cell line was used as a
model for photothermal cancer ablation. Briefly, 3 million
(3× 106) cells were counted and seeded on a 96-well plate,
with a theoretical cell count of 300,000 in each well. To
each well, 100 μl of treatment reagent was added (CNT,
POSS-PCU, or POSS-PCU-CNT). All treatments were
done in triplicates. NIR laser was then applied for 10 min-
utes. Cells were then incubated at 37°C with 5% CO2 for
24 hours, and counted thereafter. All reagents pertaining
to cell work were purchased from Invitrogen. Cell count
was done using a MACSQuant Analyzer flow cytometry
(Miltenyi Biotec Ltd. Surrey, UK).
Curve fitting and statistical analyses
Curve fitting (least squares method) and statistical ana-
lyses were conducted at a 95% confidence interval using
MATLABW (MathWorks Inc, USA). Statistical significance
testing was conducted using unpaired Student’s t-test.
P values of< 0.05 were considered statistically significant.
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